Johnson Financial Group, Inc. Intellia Therapeutics, Inc. Transaction History
Johnson Financial Group, Inc.
- $2.06 Billion
- Q2 2024
A detailed history of Johnson Financial Group, Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 3,856 shares of NTLA stock, worth $61,927. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,856Holding current value
$61,927% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
319Shares Held
88.4MCall Options Held
673KPut Options Held
865K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$197 Million2.39% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$154 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.1MShares$146 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.8MShares$77.1 Million3.53% of portfolio
-
State Street Corp Boston, MA4.36MShares$70.1 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.22B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...